Literature DB >> 27053542

Medication-related osteonecrosis of the jaw: a dentist's nightmare.

Arvind Muthukrishnan1, Laliytha Bijai Kumar1, Gomathi Ramalingam1.   

Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a complication in patients who are on anti-bone resorptive drugs. These drugs are prescribed for patients with multiple myeloma, osteoporosis, metastatic carcinoma and Paget's disease. Common anti-bone resorptive drugs such as bisphosphonate and monoclonal antibodies such as denosumab are prescribed for these patients to prevent bone resorption. Although very effective in preventing bone resorption, a complication arising from these groups of drugs is the development of osteomyelitis of the jaw. This medication-related osteonecrosis occurs only in the jaw bones. It could mimic a metastatic jaw tumour when a patient reports to the dental surgeon with pain and swelling in the jaw. This case report describes MRONJ in a 50-year-old Indian woman. This possible painful drug-induced complication of jaw bones can be prevented if proper medical history is taken and management protocol is followed in these patients. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27053542      PMCID: PMC4840656          DOI: 10.1136/bcr-2016-214626

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

Review 1.  A current update on osteonecrosis of the jaw and bisphosphonates.

Authors:  Yazdana Arrain; Tahir Masud
Journal:  Dent Update       Date:  2011-12

2.  METASTASES TO THE SKELETON, BRAIN AND SPINAL CORD FROM CANCER OF THE BREAST AND THE EFFECT OF RADIOTHERAPY.

Authors:  M Lenz; J R Freid
Journal:  Ann Surg       Date:  1931-01       Impact factor: 12.969

Review 3.  Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?

Authors:  John W Hellstein; Cindy L Marek
Journal:  J Oral Maxillofac Surg       Date:  2005-05       Impact factor: 1.895

4.  Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.

Authors:  E R Van Beek; C W G M Löwik; S E Papapoulos
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

Review 5.  Cellular and molecular mechanisms of action of bisphosphonates.

Authors:  M J Rogers; S Gordon; H L Benford; F P Coxon; S P Luckman; J Monkkonen; J C Frith
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

6.  Bisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner.

Authors:  N M H McLeod; B J B Davies; P A Brennan
Journal:  Br Dent J       Date:  2007-12-08       Impact factor: 1.626

  6 in total
  1 in total

1.  Uncommon presentation of medication-related osteonecrosis of the mandible in a patient with metastatic prostate cancer.

Authors:  Meera Thavarajah; Rahul Jayaram
Journal:  BMJ Case Rep       Date:  2019-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.